Associated Papers
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.
Lee K et al.
Blood, 2024
38985830 (PubMed )
Supplement: BLOOD_BLD-2023-021944-mmc1.pdf
Genotype-phenotype analyses of Iranian patients with hemophilia B (Leyden -) and hemophilia B (Leyden +): A single-center study.
Moghadam AA et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis, 2024
Molecular characterization of 16 hemophilia B families in Aragon, Spain.
Arias-Moreno X et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis, 2013
Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Mutation in brief #965. Online.
Mahajan A et al.
Human Mutation, 2007
Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
Karimipoor M et al.
Thrombosis Research, 2007
Molecular genotyping of the Italian cohort of patients with hemophilia B.
Belvini D et al.
Haematologica, 2005
Denaturing HPLC procedure for factor IX gene scanning.
Castaldo G et al.
Clinical Chemistry, 2003
Factor IX mutations in South Africans and African Americans are compatible with primarily endogenous influences upon recent germline mutations.
Li X et al.
Human Mutation, 2000
Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
Attali O et al.
Thrombosis and Haemostasis, 1999
A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis.
Hinks JL et al.
British Journal of Haematology, 1999
Select a paper to view details